| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Broadfoot Jill Marie is a Chief Financial Officer at ATYR, with reported holdings spanning 2 companies. Recent filings cover 6 purchases and 5 sales. Those positions are worth an estimated $120K at current prices.
Our model assigns Broadfoot Jill Marie a middling insider score of 61/100, based on 6 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +10.9%.
Broadfoot Jill Marie's largest disclosed position is in ATYR as Chief Financial Officer, worth about $120K. Net of sales, the recent Form 4 record there shows accumulation of 93,598 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | ATYR Atyr Pharma Inc | Chief Financial Officer | Sale+OE | 1,254 | $3.78 | $4,740.12 | -3.8% | -6.0% | -76.9% | |
| May 31, 2024 | ATYR Atyr Pharma Inc | Chief Financial Officer | Buy | 5,000 | $1.79 | $8,950.00 | +21.8% | +9.2% | +158.4% | |
| Feb 6, 2024 | ATYR Atyr Pharma Inc | Chief Financial Officer | Sale+OE | 1,590 | $1.69 | $2,687.10 | -7.1% | +0.6% | +138.8% | |
| Feb 6, 2023 | ATYR Atyr Pharma Inc | Chief Financial Officer | Sale+OE | 1,566 | $2.36 | $3,695.76 | -9.2% | -12.7% | -32.7% | |
| Jan 13, 2022 | ATYR Atyr Pharma Inc | Chief Financial Officer | Buy | 1,923 | $6.75 | $12,980.25 | +18.9% | -23.9% | -65.3% | |
| Feb 9, 2021 | ATYR Atyr Pharma Inc | Chief Financial Officer | Sale+OE | 390 | $7.66 | $2,987.40 | -3.8% | -50.3% | -21.4% | |
| Jun 19, 2020 | ATYR Atyr Pharma Inc | Chief Financial Officer | Buy | 1,850 | $4.22 | $7,807.00 | +25.3% | - | - | |
| Feb 7, 2020 | ATYR Atyr Pharma Inc | Chief Financial Officer | Sale+OE | 375 | $4.03 | $1,511.25 | -5.0% | - | - | |
| Sep 20, 2018 | ATYR Atyr Pharma Inc | Chief Financial Officer | Buy | 64,000 | $0.83 | $52,854.80 | +246.2% | - | - | |
| Sep 14, 2018 | ATYR Atyr Pharma Inc | Chief Financial Officer | Buy | 26,000 | $0.73 | $19,055.40 | New | - | - |